Phase II study of antineoplastons A10 and AS2-1 in patients with small cell carcinoma of the lung
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 26 Sep 2017 Status changed from active, no longer recruiting to discontinued.
- 04 Sep 2005 New trial record.